• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
The prevalence of chronic kidney disease in people with severe mental illness: A systematic review protocol.重度精神疾病患者慢性肾脏病的患病率:一项系统评价方案
PLoS One. 2025 Jan 31;20(1):e0310568. doi: 10.1371/journal.pone.0310568. eCollection 2025.
2
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
3
Prevalence of unrecognized or "silent" myocardial ischemia in chronic kidney disease patients: Protocol for a systematic review and meta-analysis.慢性肾脏病患者无症状或“沉默性”心肌缺血的患病率:系统评价和荟萃分析方案。
PLoS One. 2021 Sep 2;16(9):e0256934. doi: 10.1371/journal.pone.0256934. eCollection 2021.
4
Prevalence of Severe Mental Illness and Its Associations With Health Outcomes in Patients With CKD: A Swedish Nationwide Study.慢性肾脏病患者中严重精神疾病的患病率及其与健康结局的关联:一项瑞典全国性研究。
Am J Kidney Dis. 2025 May;85(5):577-588.e1. doi: 10.1053/j.ajkd.2024.12.004. Epub 2025 Feb 25.
5
Prevalence of polypharmacy and associated adverse health outcomes in adult patients with chronic kidney disease: protocol for a systematic review and meta-analysis.患有慢性肾病的成年患者中,多重用药的流行情况及其对健康的不良影响:系统评价和荟萃分析的方案。
Syst Rev. 2021 Jul 4;10(1):198. doi: 10.1186/s13643-021-01752-z.
6
Sexuality and intimacy among people with serious mental illness: a qualitative systematic review.严重精神疾病患者的性与亲密关系:一项定性系统综述
JBI Database System Rev Implement Rep. 2019 Jan;17(1):74-125. doi: 10.11124/JBISRIR-2017-003824.
7
Chronic kidney disease and severe mental illness: a scoping review.慢性肾脏病与严重精神疾病:范围综述。
J Nephrol. 2023 Jul;36(6):1519-1547. doi: 10.1007/s40620-023-01599-8. Epub 2023 Apr 8.
8
HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis.用于非透析慢性肾脏病患者的HMG辅酶A还原酶抑制剂(他汀类药物)
Cochrane Database Syst Rev. 2023 Nov 29;11(11):CD007784. doi: 10.1002/14651858.CD007784.pub3.
9
Interventions to integrate care for people with serious mental illness and substance use disorders: a systematic scoping review protocol.干预措施以整合严重精神疾病和物质使用障碍患者的护理:系统范围界定综述方案。
BMJ Open. 2019 Oct 30;9(10):e031122. doi: 10.1136/bmjopen-2019-031122.
10
Glucagon-like peptide 1 (GLP-1) receptor agonists for people with chronic kidney disease and diabetes.用于慢性肾病和糖尿病患者的胰高血糖素样肽1(GLP-1)受体激动剂。
Cochrane Database Syst Rev. 2025 Feb 18;2(2):CD015849. doi: 10.1002/14651858.CD015849.pub2.

本文引用的文献

1
Estimating the population-level impacts of improved uptake of SGLT2 inhibitors in patients with chronic kidney disease: a cross-sectional observational study using routinely collected Australian primary care data.评估改善慢性肾脏病患者对钠-葡萄糖协同转运蛋白2抑制剂(SGLT2抑制剂)的使用在人群层面的影响:一项使用澳大利亚常规收集的初级保健数据的横断面观察性研究。
Lancet Reg Health West Pac. 2023 Dec 18;43:100988. doi: 10.1016/j.lanwpc.2023.100988. eCollection 2024 Feb.
2
Prevalence and predictors of chronic kidney disease among type 2 diabetic patients worldwide, systematic review and meta-analysis.全球2型糖尿病患者慢性肾脏病的患病率及预测因素:系统评价与荟萃分析
Diabetol Metab Syndr. 2023 Nov 28;15(1):245. doi: 10.1186/s13098-023-01202-x.
3
Cardiovascular-Kidney-Metabolic Health: A Presidential Advisory From the American Heart Association.心血管-肾脏-代谢健康:美国心脏协会的总统顾问报告
Circulation. 2023 Nov 14;148(20):1606-1635. doi: 10.1161/CIR.0000000000001184. Epub 2023 Oct 9.
4
Antipsychotic Medication and Risk of Metabolic Disorders in People With Schizophrenia: A Longitudinal Study Using the UK Clinical Practice Research Datalink.抗精神病药物与精神分裂症患者代谢紊乱风险:一项使用英国临床实践研究数据库的纵向研究。
Schizophr Bull. 2024 Mar 7;50(2):447-459. doi: 10.1093/schbul/sbad126.
5
Improving kidney care for people with severe mental health difficulties: a thematic analysis of twenty-two healthcare providers' perspectives.改善严重精神健康障碍患者的肾脏护理:二十二位医疗保健提供者观点的主题分析。
Front Public Health. 2023 Jun 28;11:1225102. doi: 10.3389/fpubh.2023.1225102. eCollection 2023.
6
Chronic kidney disease and severe mental illness: a scoping review.慢性肾脏病与严重精神疾病:范围综述。
J Nephrol. 2023 Jul;36(6):1519-1547. doi: 10.1007/s40620-023-01599-8. Epub 2023 Apr 8.
7
Lifestyle-Related Risk Factors for the Incidence and Progression of Chronic Kidney Disease in the Healthy Young and Middle-Aged Population.生活方式相关的危险因素对健康中青年人群慢性肾脏病的发生和进展的影响。
Nutrients. 2022 Sep 14;14(18):3787. doi: 10.3390/nu14183787.
8
The lived experience of severe mental illness and long-term conditions: a qualitative exploration of service user, carer, and healthcare professional perspectives on self-managing co-existing mental and physical conditions.严重精神疾病和长期疾病的生活体验:服务使用者、照顾者和医疗保健专业人员对自我管理共存的精神和身体状况的观点的定性探索。
BMC Psychiatry. 2022 Jul 19;22(1):479. doi: 10.1186/s12888-022-04117-5.
9
The Association Between Smoking and Renal Function in People Over 20 Years Old.20岁以上人群吸烟与肾功能之间的关联
Front Med (Lausanne). 2022 Jun 3;9:870278. doi: 10.3389/fmed.2022.870278. eCollection 2022.
10
Early Identification of CKD-A Scoping Review of the Global Populations.慢性肾脏病-A的早期识别:全球人群的范围综述
Kidney Int Rep. 2022 Apr 6;7(6):1341-1353. doi: 10.1016/j.ekir.2022.03.031. eCollection 2022 Jun.

重度精神疾病患者慢性肾脏病的患病率:一项系统评价方案

The prevalence of chronic kidney disease in people with severe mental illness: A systematic review protocol.

作者信息

Carswell Claire, Bramham Kate, Chilcot Joseph, Jacobs Rowena, Osborn David, Siddiqi Najma

机构信息

Department of Health Sciences, University of York, York, United Kingdom.

King's College Hospital NHS Trust, London, United Kingdom.

出版信息

PLoS One. 2025 Jan 31;20(1):e0310568. doi: 10.1371/journal.pone.0310568. eCollection 2025.

DOI:10.1371/journal.pone.0310568
PMID:39888957
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11785261/
Abstract

BACKGROUND

People with severe mental illness (SMI) are more likely to develop long-term physical health conditions, including type 2 diabetes and cardiovascular disease, compared to people without SMI. This contributes to an inequality in life expectancy known as the 'mortality gap'. Chronic kidney disease (CKD) is a growing global health concern set to be the 5th leading cause of life-years lost by 2040. However, there is limited research exploring the relationship between CKD and SMI. This systematic review will aim to examine the prevalence and incidence of CKD among people with SMI.

METHODS

We will search Medline, Embase, PsycINFO, CINAHL, Scopus and Web of Science for primary epidemiological research reporting the prevalence or incidence of CKD among people with SMI in any setting. Retrieved records will be managed in Covidence and screened by two independent reviewers. Data will be extracted from included studies using a piloted data extraction form, and the quality of studies will be evaluated using the appropriate JBI Critical Appraisal Checklist. The certainty of evidence will be assessed using the Grading of Recommendations, Assessment, Development, and Evaluations (GRADE) approach. Data from the included studies will be narratively synthesised. Meta-analyses will be conducted using random effects models to examine the prevalence and incidence of CKD among people with SMI.

DISCUSSION

There is limited research exploring the relationship between CKD and SMI, and this proposed systematic review will be the first to examine the prevalence of CKD among people with SMI. This review will highlight the extent of the problem and provide a foundation for future research to improve health outcomes for people with SMI.

摘要

背景

与没有严重精神疾病(SMI)的人相比,患有严重精神疾病的人更有可能患上包括2型糖尿病和心血管疾病在内的长期身体健康问题。这导致了预期寿命方面的不平等,即所谓的“死亡率差距”。慢性肾脏病(CKD)是一个日益受到全球关注的健康问题,预计到2040年将成为导致生命年损失的第五大主要原因。然而,探索CKD与SMI之间关系的研究有限。本系统评价旨在研究SMI患者中CKD的患病率和发病率。

方法

我们将在Medline、Embase、PsycINFO、CINAHL、Scopus和Web of Science中检索主要的流行病学研究,这些研究报告了在任何环境下SMI患者中CKD的患病率或发病率。检索到的记录将在Covidence中进行管理,并由两名独立的评审员进行筛选。将使用预先试验的数据提取表从纳入的研究中提取数据,并使用适当的JBI批判性评价清单评估研究质量。将使用推荐分级、评估、制定和评价(GRADE)方法评估证据的确定性。将对纳入研究的数据进行叙述性综合分析。将使用随机效应模型进行荟萃分析,以研究SMI患者中CKD的患病率和发病率。

讨论

探索CKD与SMI之间关系的研究有限,而本拟议的系统评价将是首次研究SMI患者中CKD的患病率。本评价将突出问题的严重程度,并为未来改善SMI患者健康结局的研究提供基础。